146 related articles for article (PubMed ID: 25340957)
21. Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles.
Carmona S; Jorgensen MR; Kolli S; Crowther C; Salazar FH; Marion PL; Fujino M; Natori Y; Thanou M; Arbuthnot P; Miller AD
Mol Pharm; 2009; 6(3):706-17. PubMed ID: 19159285
[TBL] [Abstract][Full Text] [Related]
22. A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor.
Fitzgerald KA; Malhotra M; Gooding M; Sallas F; Evans JC; Darcy R; O'Driscoll CM
Int J Pharm; 2016 Feb; 499(1-2):131-145. PubMed ID: 26721726
[TBL] [Abstract][Full Text] [Related]
23. Development of siRNA payloads to target KRAS-mutant cancer.
Yuan TL; Fellmann C; Lee CS; Ritchie CD; Thapar V; Lee LC; Hsu DJ; Grace D; Carver JO; Zuber J; Luo J; McCormick F; Lowe SW
Cancer Discov; 2014 Oct; 4(10):1182-1197. PubMed ID: 25100204
[TBL] [Abstract][Full Text] [Related]
24. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H
Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
[TBL] [Abstract][Full Text] [Related]
25. Nonendocytic delivery of lipoplex nanoparticles into living cells using nanochannel electroporation.
Boukany PE; Wu Y; Zhao X; Kwak KJ; Glazer PJ; Leong K; Lee LJ
Adv Healthc Mater; 2014 May; 3(5):682-9. PubMed ID: 23996973
[TBL] [Abstract][Full Text] [Related]
26. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.
Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J
J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126
[TBL] [Abstract][Full Text] [Related]
27. RNA interference by nanofiber-based siRNA delivery system.
Cao H; Jiang X; Chai C; Chew SY
J Control Release; 2010 Jun; 144(2):203-12. PubMed ID: 20138939
[TBL] [Abstract][Full Text] [Related]
28. Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles.
Benfer M; Kissel T
Eur J Pharm Biopharm; 2012 Feb; 80(2):247-56. PubMed ID: 22085653
[TBL] [Abstract][Full Text] [Related]
29. Efficient Gene Knockdown in Mouse Oocytes through Peptide Nanoparticle-Mediated SiRNA Transfection.
Jin Z; Li R; Zhou C; Shi L; Zhang X; Yang Z; Zhang D
PLoS One; 2016; 11(3):e0150462. PubMed ID: 26974323
[TBL] [Abstract][Full Text] [Related]
30. In vivo activation of PEGylated long circulating lipid nanoparticle to achieve efficient siRNA delivery and target gene knock down in solid tumors.
Sasayama Y; Hasegawa M; Taguchi E; Kubota K; Kuboyama T; Naoi T; Yabuuchi H; Shimai N; Asano M; Tokunaga A; Ishii T; Enokizono J
J Control Release; 2019 Oct; 311-312():245-256. PubMed ID: 31505222
[TBL] [Abstract][Full Text] [Related]
31. Probing the nanoparticle-AGO2 interaction for enhanced gene knockdown.
Deshpande S; Singh N
Soft Matter; 2018 May; 14(20):4169-4177. PubMed ID: 29687822
[TBL] [Abstract][Full Text] [Related]
32. Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration.
Liang Y; Liu Z; Shuai X; Wang W; Liu J; Bi W; Wang C; Jing X; Liu Y; Tao E
Biochem Biophys Res Commun; 2012 May; 421(4):690-5. PubMed ID: 22542938
[TBL] [Abstract][Full Text] [Related]
33. PEGylated polyethyleneimine grafted silica nanoparticles: enhanced cellular uptake and efficient siRNA delivery.
Lee H; Sung D; Veerapandian M; Yun K; Seo SW
Anal Bioanal Chem; 2011 Apr; 400(2):535-45. PubMed ID: 21340689
[TBL] [Abstract][Full Text] [Related]
34. Molecular determinants for cyclo-oligosaccharide-based nanoparticle-mediated effective siRNA transfection.
Manzanares D; Araya-Durán I; Gallego-Yerga L; Játiva P; Márquez-Miranda V; Canan J; Jiménez Blanco JL; Mellet CO; González-Nilo FD; García Fernández JM; Ceña V
Nanomedicine (Lond); 2017 Jul; 12(13):1607-1621. PubMed ID: 28621615
[TBL] [Abstract][Full Text] [Related]
35. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
[TBL] [Abstract][Full Text] [Related]
36. Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugate.
Lee MS; Lee JE; Byun E; Kim NW; Lee K; Lee H; Sim SJ; Lee DS; Jeong JH
J Control Release; 2014 Oct; 192():122-30. PubMed ID: 24995950
[TBL] [Abstract][Full Text] [Related]
37. Bioreducible cationic polymer-based nanoparticles for efficient and environmentally triggered cytoplasmic siRNA delivery to primary human brain cancer cells.
Kozielski KL; Tzeng SY; De Mendoza BA; Green JJ
ACS Nano; 2014 Apr; 8(4):3232-41. PubMed ID: 24673565
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
[TBL] [Abstract][Full Text] [Related]
39. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
40. Efficient siRNA delivery to mammalian cells using layered double hydroxide nanoparticles.
Ladewig K; Niebert M; Xu ZP; Gray PP; Lu GQ
Biomaterials; 2010 Mar; 31(7):1821-9. PubMed ID: 19922997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
